MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA (MF-CTCL) EPIDEMIOLOGY AND TREATMENT PATHWAYS IN FRANCE AND SPAIN: NEW INSIGHTS FOR AN ACCURATE DESCRIPTION

被引：0
|
作者：
D'Agostino, P. [1 ]
Lezzi, C. [1 ]
Kent, A. [2 ]
Sharp, E. [2 ]
Schmidt, F. [3 ]
Turini, M. M. [1 ]
机构：
[1] Helsinn Healthcare SA, Lugano, Switzerland
[2] Polestar Insights, London, England
[3] Recordati Rare Dis, Puteaux La Defense, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO64
引用
收藏
页码：S852 / S853
页数：2
相关论文
共 50 条
  • [1] Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gel
    Denis, Daphne
    Beneton, Nathalie
    Laribi, Kamel
    Maillard, Herve
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2241 - 2251
  • [2] Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
    Crimp, Caitlin
    Gangal, Ameya
    Tarabadkar, Erica S.
    Shinohara, Michi M.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3271 - 3279
  • [3] Schedule frequency of chlormethine gel for patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): A real-world evidence study
    Querfeld, Christiane
    Binder, Gary
    Turini, Marco
    Gor, Deval
    Wassel, Christina L.
    Pashos, Chris
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB77 - AB77
  • [4] Clinician-level variation in mechlorethamine treatment duration in mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)
    Querfeld, Christian
    Pacheco, Theresa
    Haverkos, Bradley
    Binder, Gary
    Angello, James
    Poligone, Brian
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S8 - S8
  • [5] Maintenance therapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S45 - S45
  • [6] Concomitant use of steroids or phototherapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
    Querfeld, Christiane
    Turini, Marco
    Gor, Deval
    Angello, James T.
    Pashos, Chris
    Kim, Ellen J.
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S44 - S45
  • [7] Mycosis fungoides-type cutaneous T-cell lymphoma and neutrophilic dermatosis
    Franck, N
    Carlotti, A
    Gorin, I
    Buffet, M
    Mateus, C
    Dupin, N
    ARCHIVES OF DERMATOLOGY, 2005, 141 (03) : 353 - 356
  • [8] Treatment duration as a function of clinician-level patient volume: mechlorethamine treatment for mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)
    Querfeld, Christiane
    Pacheco, Theresa
    Haverkos, Bradley
    Binder, Gary
    Angello, James
    Poligone, Brian
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S8 - S8
  • [9] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Christiane Querfeld
    Winnie W. Nelson
    Deval Gor
    Chris L. Pashos
    Quan V. Doan
    Marco Turini
    James T. Angello
    Larisa J. Geskin
    Dermatology and Therapy, 2022, 12 : 2781 - 2795
  • [10] Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study
    Querfeld, Christiane
    Nelson, Winnie W.
    Gor, Deval
    Pashos, Chris L.
    Doan, Quan, V
    Turini, Marco
    Angello, James T.
    Geskin, Larisa J.
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2781 - 2795
12345